We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Fresenius Medical Care AG | NYSE:FMS | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.69 | -3.19% | 20.97 | 21.57 | 20.965 | 21.46 | 494,745 | 22:58:41 |
By Mauro Orru
Fresenius Medical Care AG & Co. KGaA said Thursday that it has set a new medium-term outlook through 2025.
The dialysis services provider said it expects annual average increases in the upper-single-digit percentage range for net income in the next five years and in the mid-single-digit percentage range for revenue.
The targets are in constant currency and exclude special items.
The announcement came at the company's capital markets day, where Fresenius Medical Care also set out its new strategy focusing on three key areas.
The company said it would bolster its critical care portfolio in critical care solutions, expand its network of complementary assets and develop new forms of renal therapy.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
October 08, 2020 08:10 ET (12:10 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Fresenius Medical Care Chart |
1 Month Fresenius Medical Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions